Science Explorer Interactive view Map
Company · Berwyn · United States

QR Pharma (United States)

qrpharma.comROR OpenAlex
Research works
4
▼ 36% vs 2013–17
Citations
44
11.1 per fractional work
Top-10% rate
10.1%
record average 16.5%
Open access
36%
world 28%

Not ranked overall: QR Pharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does QR Pharma (United States) publish most on?

By volume: Alzheimer's disease research and treatments, Computational Drug Discovery Methods, Cholinesterase and Neurodegenerative Diseases and Nuclear Structure and Function.

Alzheimer's disease rese…1Alzheimer's disease research and treatments: 1 fractional worksComputational Drug Disco…0Computational Drug Discovery Methods: 0 fractional worksCholinesterase and Neuro…0Cholinesterase and Neurodegenerative Diseases: 0 fractional worksNuclear Structure and Fu…0Nuclear Structure and Function: 0 fractional worksPrion Diseases and Prote…0Prion Diseases and Protein Misfolding: 0 fractional worksNuclear Receptors and Signaling: 0 fractional worksParkinson's Disease Mechanisms and Treatments: 0 fractional worksNeurological diseases and metabolism: 0 fractional worksNeurological Disease Mechanisms and Treatments: 0 fractional worksNeuroinflammation and Neurodegeneration Mechanisms: 0 fractional works
PhysiologyComputational Theory and MathematicsPharmacologyMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Alzheimer's disease research and treatments Physiology 1 works
  2. 2 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  3. 3 Cholinesterase and Neurodegenerative Diseases Pharmacology 0 works
  4. 4 Nuclear Structure and Function Molecular Biology 0 works
  5. 5 Prion Diseases and Protein Misfolding Molecular Biology 0 works
  6. 6 Nuclear Receptors and Signaling Cellular and Molecular Neuroscience 0 works
  7. 7 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
  8. 8 Neurological diseases and metabolism Neurology 0 works
  9. 9 Neurological Disease Mechanisms and Treatments Neurology 0 works
  10. 10 Neuroinflammation and Neurodegeneration Mechanisms Neurology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.5%not open63.5%

World: 28% of research is openly available.

with international co-authors22.2%domestic only77.8%

World: 19% is written across borders.

How has QR Pharma (United States)'s research output changed?

Output in 2018–2022 was 36% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Berwyn

All research institutions in Berwyn

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.